AGLE
Aeglea BioTherapeutics Inc
Halal Rating :
Last Price
$20.60
Last updated:
Market Cap
-
7D Change
-4.41%
1 Year Change
-24.07%
Company Overview
Exchange
Next Earnings Date
Aeglea BioTherapeutics Inc is a clinical-stage biotechnology company that develops human enzyme therapeutics for rare metabolic diseases. The company focuses on developing medicines that address unmet medical needs in rare diseases. Their main therapeutic programs aim to treat genetic disorders and cancer metabolism.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Aeglea BioTherapeutics Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.